
Australian Clinical Labs Investor Relations Material
Latest events

H2 2025
Australian Clinical Labs
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Australian Clinical Labs Limited
Access all reports
Australian Clinical Labs Limited (ACL) is a private provider of pathology services in Australia, operating over 70 accredited laboratories. Annually, these laboratories conduct millions of test episodes for both clinicians and patients. ACL serves more than 90 public and private hospitals, including two of the largest private hospital groups in Australia, with a comprehensive range of services encompassing routine pathology tests, advanced molecular genetics testing, and pathology services for clinical trials, among others. The company is headquartered in Clayton, Victoria, and its shares are listed on the ASX.
Key slides for Australian Clinical Labs Limited


H2 2025
Australian Clinical Labs Limited


H2 2025
Australian Clinical Labs Limited
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ACL
Country
🇦🇺 Australia